| Message: | The importance of biomarkers in drug discovery is now constantly increasing. In in vivo pharmacokinetic studies of drug development, a biomarker can be used to monitor disease progress, confirm mechanism of action, and also be used as a surrogate for a natural endpoint to assess drug efficacy and safety. Creative Biolabs is a world top CRO focused on drug discovery, with decades of experience in conducting in vivo PK assays to evaluate the effectiveness and safety of drug candidates. A team of senior scientists is proud to provide flexible PK biomarker assessment services that incorporate with other effective assays, to ensure greater prediction of success for preclinical and clinical studies.
Biomarkers are applied in a wide range of scientific fields to evaluate normal and pathogenic processes or the response to treatment. More generally, biomarker can be used as an indicator of a certain disease state or the treatment status of an organism, and also be applied to diagnose disease risk, and contribute to choosing drug treatment or administration regimes. In the drug development progress, molecular biomarkers are used in several areas, such as early drug development studies, safety studies, proof of concept studies, and molecular profiling. https://www.creative-biolabs.com/drug-discovery/therapeutics/pk-biomarker-assessment.htm. |
my account
